BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2018

Nov 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2018-11-02

Reporting Person: Powell Lynne (Senior VP - CCO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-02	Common Stock	M	1000	$3.22	Acquired	9605	Direct
2018-11-02	Common Stock	S	1000	$8.00	Disposed	8605	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-02	Emp. Stock Option (Right to Buy)	$3.22	M	1000	Disposed	2026-05-23	Common Stock (1000)	Direct

Footnotes

F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2018.